» Articles » PMID: 23267066

Neddylation Pathway Regulates T-cell Function by Targeting an Adaptor Protein Shc and a Protein Kinase Erk Signaling

Overview
Specialty Science
Date 2012 Dec 26
PMID 23267066
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

NEDD8 (neural precursor cell expressed, developmentally down-regulated 8) is a ubiquitin-like molecule whose action on modifying protein substrates is critical in various cellular functions but whose importance in the immune system is not well understood. Here we investigated the role of protein neddylation in regulating T-cell function using an in vivo knockdown technique. We found that reduced expression of Ubc12 in CD4(+) T cells led to impaired T-cell receptor/CD28-induced proliferation and cytokine production both in vitro and in vivo, accompanied by reduced Erk activation. These findings were recapitulated by treatment with MLN4924, an inhibitor of NEDD8-activating enzyme. Furthermore, Shc, an adaptor molecule between antigen receptors and the Ras/Erk pathway, was identified as a target for neddylation. Importantly, mice adoptively transferred with Ubc12 knockdown CD4(+) T cells showed markedly ameliorated allergic responses. This study thus identifies an important role for protein neddylation in T-cell function, which may serve as a therapeutic target for inflammatory diseases.

Citing Articles

Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer.

Powell R, Rinkenbaugh A, Guo L, Cai S, Shao J, Zhou X NPJ Breast Cancer. 2024; 10(1):37.

PMID: 38802426 PMC: 11130334. DOI: 10.1038/s41523-024-00644-4.


Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer.

Papakyriacou I, Kutkaite G, Rubies Bedos M, Nagarajan D, Alford L, Menden M Nat Commun. 2024; 15(1):3581.

PMID: 38678024 PMC: 11055868. DOI: 10.1038/s41467-024-47987-x.


Protein neddylation and its role in health and diseases.

Zhang S, Yu Q, Li Z, Zhao Y, Sun Y Signal Transduct Target Ther. 2024; 9(1):85.

PMID: 38575611 PMC: 10995212. DOI: 10.1038/s41392-024-01800-9.


Neddylation Regulation of Immune Responses.

Mao H, Lin X, Sun Y Research (Wash D C). 2024; 6:0283.

PMID: 38434245 PMC: 10907026. DOI: 10.34133/research.0283.


Advancements in colorectal cancer research: Unveiling the cellular and molecular mechanisms of neddylation (Review).

Wang T, Li X, Ma R, Sun J, Huang S, Sun Z Int J Oncol. 2024; 64(4).

PMID: 38391033 PMC: 10919758. DOI: 10.3892/ijo.2024.5627.


References
1.
Zhang L, Lorenz U, Ravichandran K . Role of Shc in T-cell development and function. Immunol Rev. 2003; 191:183-95. DOI: 10.1034/j.1600-065x.2003.00025.x. View

2.
Soucy T, Dick L, Smith P, Milhollen M, Brownell J . The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy. Genes Cancer. 2011; 1(7):708-16. PMC: 3092238. DOI: 10.1177/1947601910382898. View

3.
Soucy T, Smith P, Milhollen M, Berger A, Gavin J, Adhikari S . An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature. 2009; 458(7239):732-6. DOI: 10.1038/nature07884. View

4.
Lin J, Milhollen M, Smith P, Narayanan U, Dutta A . NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells. Cancer Res. 2010; 70(24):10310-20. PMC: 3059213. DOI: 10.1158/0008-5472.CAN-10-2062. View

5.
Liu Y, Penninger J, Karin M . Immunity by ubiquitylation: a reversible process of modification. Nat Rev Immunol. 2005; 5(12):941-52. PMC: 7096784. DOI: 10.1038/nri1731. View